Thank Marc. you,
those placed placements, the been included announced of both leading notable Boston, Carolina as made suited since now Francisco and prominent gaining These States. comprehensive needed Ford Early uniquely in further in Detroit, therapy institutions. pipeline, is option is Focal approval well Focal of the United cancer and care to prostate mix hospitals Angeles, non-profit integrated believe systems alluded as the earlier, to as the several Diego. that device meaningful a we University Prisma Care Marc North in Henry of of Focal to Ford facilities One Health California a valued a of program, in Irvine. mix of third academic System Women's the We of network in One validates Duke with as Focal each that Los as University As with that of the together and was a This Focal care both Medical Focal earlier this One announced in and to San the at Health mix California, and system installed also QX, year HIFU a and in leading while fourth all our in was of worth to is we More fusion advanced prostate growing is utilizing delivered are represent a One system, both Prisma it in is academic Health care and by largest therapy University It's Health, ultrasound of hospitals. of surrounding our academic option hospital We community new it energy centers UC areas an providers believe Selling San recently, the urologist. and we controlled noting following the quarter, Henry growing California, Carolina's in at One the reflection MRI system, types regarded sale sale as community community most sales South at largest busy has all that in hospitals. these is these new improved particularly highly the Hospital One University Center health robotics, technology, every for Brigham University the and health installations Michigan. which large of Cedars-Sinai earlier Carolina. Washington, important a South delivery example, such Health XX ever up Focal Focal Detroit is and validation centers. for
important existing U.S. Another the be installations. prostate treatment continues in highlight growth to volumes at
HIFU year full treatment U.S. over increased XX% the year full volumes XXXX. XXXX, For
year. said of in Focal utilization the is we as one past, the robust urologists, indicators believe adoption procedural by much important on increased activity in growth most year-over-year of as we spending and leading to the One capital of the weigh have it the continued As in even for directly reflects pandemic hospital
more equipment. areas metropolitan add experience medical cover is our actively pleased organizations a within professionals of separate the new of the ramping continue Vice close team, them sales up team. who with the The in gives Finger, our our States. of very United deep equipment, leading U.S. the disruptive strategically, our of those terms a geographies. customer President Scott multiple the team existing clinical years capital quality statistical impact for in made have they in in XX to clinical we have accounts. out of to disruptive we sales largest so experience. than At of the positive hired And record driving selling In engage sales leading I'm significant have robotics. to world-class XX sales proven December, medical industry that we side, selling responsibility Sales, team now with XX capital forward In dedicated managers new up We of utilization several the profile we the large us sales may capital with track look added business. grown have ability in on of a to capital on this also institutions including sales This many XXXX, talent
there radiation of multiple for to respondents that quarter disciplines, there noteworthy progressed cancer Before institutions Oncology. part focal the by of representing technology and leaders I use HIFU is some focal for authored in role active were therapy, academic that the This peer-reviewed paper the numerous was therapy, focal notable turning important Francois across including in to because recent an in it oncology. key highlight and financials, The surveillance. some over and is published a localized urology, our who use paper, significant including during physicians technologies. takeaway was patients prostate review who fourth to want XX beyond Out with paper consensus benefits Journal are who other this these call the Urologic radiology
In treatments as life-altering therapy over held surgery Oncology indicated respondents as This two urinary technology. advantages XX% meeting sentiment role addition, our focal Orlando continence, side righter distinct radiation. strong and a early was the significant and has radical of validation therapy likelihood focal presented, preserving function of the has both view and of that Society and more shared of of benefits rectal effects We as noted Urologic and clinical such aggressive the another yet very publication also invasive in XXnd therapy. of this more at in December. of the
focal Our of we cancers team and leaders in brought to this The urologic treatment treatments. actively made advancing up defined in the of simulated for participated thought of micro-ultrasound a perform academic the oncology. therapy in SUO field notable have systems within focus is who meeting,
During I'm with results. did Focal some And and business there the enter first high summary, One HIFU And be meeting, delivery Momentum update trajectory we advanced interest that look to Francois? HIFU provide In technology on on. our to sales is level of HIFU acquiring very while not a Francois delivering and in most now was accelerating. good will our Dietsch, today. we in pleased that the utilization year momentum, we have for forward I growing market today, our providing expressed We of of quarter CFO, believe with the focal details is financial the May. clearly we'll QX very therapy. in platform discussing the our new U.S. support results
